INTRODUCTION
Endothelial cells (EC) account for only 1-2% of all cells in the body, but in the average size adult, EC cover a surface area over 1000 m 2 and weigh approximately 1 kg (1, 2) . Because of their role as a barrier to the plasma compartment, they are known to modulate atherogenesis in multiple ways (3, 4) . When inflamed and affected by factors, such as hypercholesterolemia, hypertension, and type 2 diabetes, EC express several adhesion proteins (5) . Monocytes and T-cells attach to these adhesion proteins and gain entry into subendothelial space, where they initiate the development of atherosclerosis. EC also express several scavenger receptors, including CD36 and Lox-1, which mediate the uptake of oxidized LDL and promote atherosclerosis (6) . The EC surface is also the site of action of lipoprotein lipase, hepatic lipase and endothelial lipase, which promote the lipolysis of lipoproteins and facilitate the transfer of lipids across the vessel wall (3, 7) .
Reverse cholesterol transport (RCT) is the pathway by which excess cellular cholesterol is removed by HDL from peripheral cells and transported to the liver for excretion (8, 9) . Based on various transgenic and Ko mouse models (10) (11) (12) (13) (14) , ABCA1 is known to play a key role in the biogenesis of HDL. Approximately 70% of nascent HDL is made in the liver when apoA-I, which is also produced by hepatocytes, interacts with hepatic ABCA1 transporters (13, 14) . The only other tissue that synthesizes significant amounts of apoA-I and also expresses ABCA1 is the intestine, which is thought to be responsible for most of the remainder of nascent HDL formation (14) . The lipidation by ABCA1 of apoA-I released from lipoproteins, during remodeling by lipases and other enzymes and lipid transfer proteins, also contributes to the maintenance of plasma HDL-cholesterol (HDL-C) (15) .
EC express several genes involved in RCT, such as ABCA1, ABCG1 and SR-B1 (16) (17) (18) , which are key transporters and receptors that are known to promote either the cellular efflux or uptake of cholesterol to and from HDL. Endothelial expression of ABCG1 was recently shown to protect against endothelial dysfunction in mice fed high fat high cholesterol (HFHC) diet (19) . It is also has been shown that ABCA1 participates in the transport of lipid-poor apoA-I across EC, whereas ABCG1 and SR-B1 facilitate by guest, on November 9, 2017 www.jlr.org Downloaded from the transcytosis of HDL across endothelium (18, 20, 21) . In order to further examine the role of ABCA1 in EC, we describe the development of transgenic mice overexpressing human ABCA1 (hABCA1), using the endothelial specific Tie2 promoter (22) . Endothelial specific expression of hABCA1 was found to raise plasma HDL-C and reduce dietinduced atherosclerosis.
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MATERIALS AND METHODS
Generation of Tie2hABCA1 transgenic mice
Full-length (6.88-kb) hABCA1 cDNA was flanked by Not I linkers and inserted into a unique Not I cloning site of the expression vector pSPTg.T2FpAXK (22, 23) . The vector has a 2.1 kb mouse Tie2 promoter, a SV40 3' terminal untranslated sequence with a polyA signal and a 1.6 kb Tie2 enhancer, which results in specific transgene expression in EC of mice (22, 23 Western blot analysis was done, as previously described (25) , with an anti-ABCA1 antibody from Abcam (ab18180), which reacts with ABCA1 from both human and mouse tissue. Anti-human/mouse β-actin was used as a control. 
Animal studies
Analyses of plasma lipids, lipoproteins
Total cholesterol, triglycerides, phospholipids, and free cholesterol in EDTAplasma were quantified after a 4-h fast, using enzymatic kits, as described elsewhere (27) . HDL-C was determined after precipitation of apoB-containing lipoproteins, with
Raichem HDL-Cholesterol reagent.
Cell culture studies
Resident mouse peritoneal macrophages were obtained after peritoneal lavage (28), with 10 ml of sterile PBS without Ca 2+ and Mg
2+
, containing 50 µg/ml of heparin.
Cells from 10 mice were placed into 6-well tissue culture plates and allowed to adhere for 1.5 h in serum-free DMEM or RPMI-1640, after which non-adherent cells were removed by rinsing with PBS. Adhered cells were directly used for RNA isolation.
Mouse aortic EC were isolated from aorta tissue explants, following published protocols (29, 30) . Mouse lung EC for efflux studies were isolated by a immunomagnetic method (31), using two rounds of selection (see Supplemental Material for detailed protocols).
Cultured mouse lung and aortic EC, which were approximately 90% pure as determined by staining with Dil-acetylated LDL (32), had a characteristic cobblestone appearance when confluent, and formed tube-like structures when pre-confluent on dishes covered
by Poly-D-lysine. Both aortic and lung EC were used at passage numbers less than 5.
Normal human primary aortic EC (ATCC number PCS-100-011) and human and re-suspended in 1 ml of PBS with 0.1% BSA. A total of 5 rounds of cell purification were performed and EC were re-suspended in 500 µl of PBS with 0.1% BSA. Isolated vascular EC were shown by flow cytometery to have 95% purity and 85% viability, using the FITC-conjugated anti-CD102 antibody and 7-AAD.
Cholesterol efflux to apoA-I and HDL was measured in quadruplicate, in at least two independent experiments, as previously described (33 , and cholesterol efflux to apoA-I or HDL diluted in serum-free growth media, supplemented with 0.1% BSA, was monitored after 18 h.
Statistical analysis
Unless otherwise indicated, all data were analyzed by Student's t-test with 
RESULTS
Expression of hABCA1 transgene and endogenous genes
Except for the liver, hABCA1 expression was observed in all tissues tested. Using total tissue homogenates, the level of hABCA1 mRNA expression on a normal chow diet compared to the endogenous murine Abca1 gene ranged between 1-12%, depending on the tissue (Fig. 1A) . Because EC typically comprise less than 1-2% of all cells in most tissues (1, 2) , the ABCA1 expression values from total tissue homogenates is an underestimate of the level of hABCA1 expression in endothelial cells. In order to better examine this issue, we compared the level of hABCA1 in EC isolated from the lung of transgenic mice, human primary aortic EC and the human EA.hy926 endothelial cell line and found a 4.5-11-fold higher level of mRNA for hABCA1 in the cells from the transgenic mice (Fig. 1B ). When we compared the level of hABCA1 to mAbcA1 in isolated lung EC from transgenic mice, we observed an approximate 2-fold increase in the enrichment of hABCA1 compared to what was observed for total lung tissue homogenates (Fig. 1A) . The level hABCA1 mRNA, however, was only 10.3 ± 3%
relative to that of mAbcA1 in isolated lung EC. By Western blot analysis of primary cultures of aortic EC, the total level of ABCA1 protein was 1.7-fold higher (P< 0.05) in transgenic mice versus control mice (Fig. 1C ).
Tie2 promoter constructs, containing a longer promoter segment than used in this study, have also been reported to be active in macrophages of transgenic mice (34) . In order to confirm the endothelial specificity of hABCA1 expression, we compared the level of hABCA1 in lung EC and peritoneal macrophages ( Fig. 2A) . The relative expression of hABCA1 in lung EC was more than 80-fold higher than in peritoneal macrophages, which only showed trace expression of hABCA1. These results are consistent with the known endothelial specificity of the 2.1 kb-Tie2 promoter coupled with the 1.6 kb-Tie2 enhancer used in this study (22, 23) .
The expression of the hABCA1 transgene in EC of mice did not significantly alter the expression of endogenous mouse Abca1, Abcg1 or Sr-b1 genes in most tissues tested, or in isolated lung EC and peritoneal macrophages ( P<0.03). Lung EC and macrophages, however, had a similar high level of Abcg1 expression in both normal and transgenic mice, which was 3 ± 0.7 fold higher than in liver (P<0.001) (Fig.2D ). We also examined the level of apoA-I gene expression in isolated lung EC, peritoneal macrophages and aorta, because apoA-I has been reported to be produced by endothelial cells lining the blood brain barrier (35, 36) , but only trace amounts of apoA-I mRNA were detected in these tissues and cells (data not shown).
Effect of hABCA1 transgene on cholesterol efflux
The functional impact of hABCA1 expression in EC was evaluated by cholesterol efflux studies (Fig. 3) . Experiments with primary cultures of aortic EC isolated from Tie2hABCA1 transgenic and C57Bl/6N control mice showed that overexpression of hABCA1 transgene in EC was accompanied by a 2.6 ± 0.6 fold increase in cholesterol efflux to apoA-I (P<0.00001) (Fig. 3A) . No difference in the amount of cholesterol efflux between control and transgenic aortic EC was observed when HDL was used as an acceptor.
To examine just the role of the transgene in cholesterol efflux, EC were isolated from Tie2hABCA1 x AbcA1-Ko mice, as well as from AbcA1-Ko mice and wild-type C57Bl/6N control mice (Fig. 3B ). Because we were unable to obtain aortic EC from tissue explants from AbcA1-Ko mice, only lung EC were used for this part of the study.
As expected, cholesterol efflux to apoA-I was not observed from lung EC isolated from AbcA1-Ko mice. Cholesterol efflux, however, was approximately 30% higher (P<0.03)
for cells from Tie2hABCA1 x AbcA1-Ko versus control mice. No significant differences were observed when HDL was used as an acceptor, except for a modest decrease in cholesterol efflux from cells isolated from AbcA1-Ko mice.
Effect of hABCA1 transgene on plasma lipids
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Tie2hABCA1 transgenic mice had approximately a 25% increase (P<0.0001) in plasma HDL-C compared to control mice on a normal chow diet (Table 2) . They also had slightly higher plasma phospholipids, total cholesterol, and lower triglycerides. On apoE-Ko or AbcAI-Ko background, the hABCA1 transgene did not, however, significantly alter plasma HDL-C (Table 2 ). In transgenic mice on AbcA1-Ko background, the level of plasma triglycerides and phospholipids was also increased in comparison with non-transgenic sibling control but no effect from the transgene was observed on HDL-C, which was undetectable in both the transgenic Tie2hABCA1 x AbcA1-Ko mice and the AbcA1-Ko mice (Table 2) . When placed on a HFHC diet for 6 months, Tie2hABCA1 transgenic mice had 40% higher (P<0.003) HDL-C than control mice (Table 2 ), but no other significant lipid changes were observed. In the absence of endogenous AbcA1, lipid profiles of plasma taken from the transgenic mice after 1.5 month on HFHC diet did not significantly differ from non-transgenic sibling control (data not shown).
Effect of hABCA1 transgene on atherosclerosis
After 6 months on a HFHC diet, Tie2hABCA1 transgenic mice had approximately 40% less (P<0.02) aortic surface lesions compared to C57Bl/6N control mice (Fig. 4A ).
The effect of the hABCA1 transgene on atherosclerosis was also confirmed in a second study, when Tie2hABCA1 transgenic mice and their non-transgenic sibling controls were placed on HFHC diet for 3 months. Because of relatively short time of this study, only a limited amount of atherosclerosis, however, was observed (Supplemental Fig. 1 ).
When the Tie2hABCA1 transgene was transferred onto an AbcA1-Ko background, however, no significant atheroprotection from the transgene or change in plasma lipids was observed (Fig. 4B) . Similarly, no effect of the hABCA1 transgene was observed in plasma lipids (Table 2 ) or in the level of atherosclerosis when expressed in mice on an apoE-Ko background (Fig. 4C) .
Effect of HFHC diet on expression of hABCA1 and endogenous genes
The HFHC diet for 3-months significantly induced in control mice the expression of mouse Abca1 and Abcg1 in several different tissues, but particularly in the liver and by guest, on November 9, 2017 www.jlr.org Downloaded from kidney (Fig. 5A) . In contrast, endogenous Sr-b1 did not show major gene expression changes in response to the diet. Overall, the gene expression changes observed from the HFHC diet treatment in the Tie2hABCA1 transgenic mice were more blunted compared to control mice, particularly for mAbcA1 (Fig. 5B) . Only changes for increased expression of Abcg1 in heart and liver and Sr-b1 in the liver were statistically significant.
As expected, the HFHC diet also did not cause major changes in the tissue expression of the hABCA1transgene when under the control of the heterologous Tie2 promoter (Fig. 1A) .
Aortic gene expression was also analyzed after 3-months on a HFHC diet, using RT 2 Profiler PCR array system for genes related to endothelial cell function (see Supplementary Tables 2 and 3 ). The expression of 9 out of the 84 examined genes was found to be changed in Tie2hABCA1 transgenic mice compared to control mice ( (Fig. 6B) . Several of the remaining 6 genes with decreased expression in the aortas of transgenic mice, namely Casp6, Cxc11, Pecam1, Ripk1, Sod1 and Tnfsf10 (Fig. 6A) , are known to be down-regulated in normal aortas compared to atherosclerotic plaques (40) (41) (42) .
DISCUSSION
The two main findings of this study are that increased endothelial specific expression of hABCA1 was associated with increased HDL-C and protected against diet-induced atherosclerosis in C57Bl/6N mice. These changes were observed despite the fact that the level of expression of hABCA1 in aortic EC of transgenic mice was relatively modest (Fig. 1) . Based on Western blot analysis, there was a 1.7-fold increase in total ABCA1
protein in aortic EC from transgenic mice compared to control mice (Fig. 1C) , which is similar to the induction, observed for endogenous mouse AbcA1 mRNA in the aorta of by guest, on November 9, 2017 www.jlr.org Downloaded from mice placed on a HFHC diet (Fig. 5) . Level of hABCA1 mRNA in lung EC from transgenic mice was significantly higher (4.5-11-fold increase) compared to cultured human primary aortic cells or the EA.hy926 human endothelial cell line (Fig. 1B) . In contrast, hABCA1 mRNA was present at approximately 10% of the level of mouse AbcA1 in lung EC isolated from transgenic mice. Some of these apparent differences in the level of hABCA1 are likely due to rapid gene expression changes in cells once isolated from tissues and or perhaps differences in the expression of genes in endothelial cells from different tissues (2, 43) . Besides having a different promoter, the transgene also had a heterologous SV40 3' UTR, which could have potentially improved the translation of the transgene transcript compared to the endogenous gene. Based on the cholesterol efflux results, the level of increased expression of hABCA1 in the aortic EC from transgenic mice was enough to increase cholesterol efflux to apoA-I by approximately 2.6-fold (Fig. 3A) and to restore cholesterol efflux to normal levels in lung EC when on the AbcA1-Ko background (Fig. 3B) . Overall, these results are consistent with only a relatively low level of hABCA1 transgene expression in EC but within a physiologic range and sufficient to alter cholesterol efflux.
Besides AbcA1, mouse EC were also found to express AbcG1 and Sr-b1 ( Fig. 2B and C), which can also contribute to cholesterol efflux. From data presented in Fig. 2D and Table 1 , it is evident that lung EC had relatively high level of expression of AbcG1, which was close to the level found in peritoneal macrophages and exceeded that found in the liver by approximately 3-fold. Lung EC had especially high level of Sr-b1 expression, which was 18-fold higher than in macrophages and was comparable to the level observed in the liver (Fig. 2B, C and D) . This observed pattern of relatively high expression of these other transporters, probably reflects their role in cholesterol trafficking of EC. As can be observed in Fig. 5 , the expression of the hABCA1 transgene appeared to blunt the induction of the endogenous Abca1 gene in the aorta of the transgenic mice when placed on a HFHC diet but did not affect the expression of the other endogenous genes that can modulate cholesterol efflux, namely Abcg1 and Sr-b1.
Tie2hABCA1 transgenic mice were observed to have a 25% increase in HDL-C when on a normal chow diet compared to control mice (Table 2) . Interestingly, the transgene in EC was only able to influence the level of HDL-C in the presence of the by guest, on November 9, 2017 www.jlr.org Downloaded from endogenous mouse AbcA1 gene or, in other words, only when the liver and intestine were able to produce nascent HDL, which then interacts with ABCA1 in peripheral cells (14, 15, 44) . When the Tie2hABCA1 transgene was transferred onto AbcA1-Ko mice, HDL-C was still very low (Table 2) , despite the fact that in vitro isolated EC from these mice were able to efflux cholesterol to apoA-I (Fig. 3B) . Unlike brain capillary EC, which are able to express and secrete apoA-I (35, 36) , the expression of apoA-I in EC from other sites was undetectable, which could account for the dependence of EC for nascent HDL produced by the liver and intestine to act as an acceptor for cholesterol efflux stimulated by ABCA1 in EC. Endothelial expression of hABCA1 transgene was also unable to affect the level of plasma HDL-C in apoE-deficient mice ( Table 2) . It was previously shown that the expression of the hABCA1 transgene in liver of apoE-Ko mice also has a minimal effect on plasma lipids, and in fact, increased aortic lesion area compared to apoE-Ko animals (45) . The mechanism for the low levels of HDL-C in apoE-Ko mice is not known, but apoE has been proposed to play an important role in the biogenesis and metabolism of HDL, at least in mice (46, 47) .
In this study the effect of Tie2hABCA1 transgene was specifically determined in lung and aortic EC, where the transgene increased level of expression of ABCA1 and cholesterol efflux to apoA1 ( fig. 1C and Fig.3 ). EC from different areas of the vasculature can display remarkable heterogeneity in structure and function (2, 43) . The Tie2 promoter is known, however, to be expressed in most EC (22, 23) , but whether increased ABCA1 expression in a particular tissue or site in the vasculature was more critical to the observed changes in HDL metabolism or atheroprotection was not assessed in this study.
Tie2hABCA1 transgenic mice were also observed to have decreased atherosclerosis when placed on HFHC diet compared to control mice (Fig. 4A ). This may be related to the 40% increase in HDL-C in the transgenic mice on the HFHC diet (Table 2) . When the Tie2hABCA1 transgene was transferred to the AbcA1-Ko or apoEKo mice and no changes were found in HDL-C, there was no apparent protection from the transgene on atherosclerosis (Fig. 4B and C) . Besides the effect of HDL in promoting cholesterol efflux, the increased HDL in the transgenic mice could also have reduced atherosclerosis by some of the other beneficial properties of HDL (48) . For by guest, on November 9, 2017 www.jlr.org Downloaded from example, HDL has been shown to reduce inflammation by suppressing activation of NFkappa B, and also by decreasing the expression of adhesion proteins (48) (49) (50) . We observed that in the aortas of theTie2hABCA1 transgenic mice on a normal chow diet, but not the HFHC diet, there was increased expression of eNOS (Fig. 6B) , which is known to have several anti-atherogenic effects (49, 51) . Caspase 6, Ripk1 (receptor (TNFRSF)-interacting serine-threoninekinase 1) and Tnfsf10 (Tumor necrosis factor (ligand) superfamily, member 10) were found to be down-regulated in the Tie2hABCA1 transgenic mice (Fig. 6A) and are known to play important roles in programmed cell death or apoptosis (40) (41) (42) .The expression of Cxcl1 (chemokine (C-X-C motif) ligand 1)
and Pecam1 (platelet/EC adhesion molecule 1), which promote transendothelial migration of leukocytes and vascular inflammation (52, 53) were also down-regulated. In contrast, the expression of the anti-atherogenic genes Rhob, which is involved in angiogenesis and EC survival (37) and Tfpi, an anti-coagulant factor protein (38) were increased in Tie2hABCA1 transgenic mice compared to control mice on a HFHC diet (Fig. 6A ).
It is known that a number of inflammatory disorders, such as systemic vasculitis, Kawasaki disease and Behcet's disease, are associated with low HDL, endothelial dysfunction and pro-atherogenic gene expression (54) (55) (56) (57) . Endothelial dysfunction can also occur in diabetes (58) and hypertension (59) , and is often also associated with decreased HDL-C (60, 61). The mechanistic link between endothelial dysfunction and HDL-C is not clear but is likely related to increased production of inflammatory cytokines and their effect in suppressing HDL production and accelerating its catabolism (62) . Low HDL can then further negatively impact on endothelial function, leading to the rapid progression of atherosclerosis (63, 64) . Results from this study, therefore, suggest that endothelial expression of ABCA1 can perhaps play an important role in these diseases and in this complex interrelationship between endothelial dysfunction, low HDL and atherosclerosis.
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